Clinical Trial Update: A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effect of CJ-023,423 on the incidence of stomach ulcers in patients with osteoarthritis; the study conducted by Pfizer has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• CJ-023,423

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED